MedPath

Comparison of intravenous levetiracetam and phenobarbital in neonatal seizures

Phase 3
Recruiting
Conditions
eonatal Seizures.
Epilepsy and recurrent seizures
Registration Number
IRCT20190526043717N1
Lead Sponsor
Ghoum University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

require for neonatal seizures management
Weight > 2500gr
birth age>37 weaks
Individuals without renal dysfunction
Individuals without dysfunction of the immune system

Exclusion Criteria

Healthy individuals
Weight <2500 gr
Birth age <37 weaks
renal dysfunction
immune system dysfunction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Seizures. Timepoint: 30 min, 24 h up to 1 w, 1th m, 2th m, 3th m. Method of measurement: clinical observation.
Secondary Outcome Measures
NameTimeMethod
eonatal seizures recurrence. Timepoint: 24 h up to 1 weak, first month, two month, and three month after intervention. Method of measurement: clinical observation.
© Copyright 2025. All Rights Reserved by MedPath